Newleos Therapeutics, Inc., a clinical-stage biotechnology company developing innovative treatments for neuropsychiatric disorders, today announced that the first participant has been dosed in the ...
News-Medical.Net on MSN
UC Davis team creates new class of serotonin-effecting drugs
UC Davis researchers have developed a new method that uses light to transform amino acids - the building blocks of proteins - ...
A case-based examination of oral lavender essential oil as a non-pharmaceutical intervention for generalized anxiety disorder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results